219 related articles for article (PubMed ID: 19631740)
1. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
[TBL] [Abstract][Full Text] [Related]
2. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
Thumma S; Repka MA
Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
[TBL] [Abstract][Full Text] [Related]
3. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
4. Modification of pharmacological activity of nebivolol due to Maillard reaction.
Patil DD; Patil CR
Pharm Dev Technol; 2013; 18(4):844-51. PubMed ID: 23668372
[TBL] [Abstract][Full Text] [Related]
5. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
Late SG; Banga AK
Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
[TBL] [Abstract][Full Text] [Related]
6. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
Fathy M; Hassan MA; Mohamed FA
Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical analysis and nonisothermal kinetic study of sertraline-lactose binary mixtures.
Ghaderi F; Nemati M; Siahi-Shadbad MR; Valizadeh H; Monajjemzadeh F
J Food Drug Anal; 2017 Jul; 25(3):709-716. PubMed ID: 28911656
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
[TBL] [Abstract][Full Text] [Related]
9. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
11. The development of microthermal analysis and photothermal microspectroscopy as novel approaches to drug-excipient compatibility studies.
Harding L; Qi S; Hill G; Reading M; Craig DQ
Int J Pharm; 2008 Apr; 354(1-2):149-57. PubMed ID: 18162342
[TBL] [Abstract][Full Text] [Related]
12. Drug-excipient compatibility studies in binary mixtures of avobenzone.
Ceresole R; Han YK; Rosasco MA; Orelli LR; Segall A
J Cosmet Sci; 2013; 64(5):317-28. PubMed ID: 24139431
[TBL] [Abstract][Full Text] [Related]
13. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
Verma RK; Garg S
J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
[TBL] [Abstract][Full Text] [Related]
14. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
[TBL] [Abstract][Full Text] [Related]
15. Determination of acyclovir in horse plasma and body fluids by high-performance liquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry.
Maes A; Garré B; Desmet N; van der Meulen K; Nauwynck H; De Backer P; Croubels S
Biomed Chromatogr; 2009 Feb; 23(2):132-40. PubMed ID: 18823074
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Possible Maillard Reaction Between Acyclovir and Dextrose upon Dilution Prior to Parenteral Administration.
Siahi Shadbad MR; Ghaderi F; Hatami L; Monajjemzadeh F
AAPS PharmSciTech; 2016 Dec; 17(6):1491-1499. PubMed ID: 26863890
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation.
Kumar V; Shah RP; Malik S; Singh S
J Pharm Biomed Anal; 2009 May; 49(4):880-8. PubMed ID: 19217740
[TBL] [Abstract][Full Text] [Related]
18. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
Yu K; Little D; Plumb R; Smith B
Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
20. Solid-state compatibility studies using a high-throughput and automated forced degradation system.
Wakasawa T; Sano K; Hirakura Y; Toyo'oka T; Kitamura S
Int J Pharm; 2008 May; 355(1-2):164-73. PubMed ID: 18215480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
